5 Results for "

LS-174T

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "LS-174T" in MCE Product Catalog:

Cat. No.: HY-153090
CAS No.: 419547-73-2
Purity:  99.59%
Target:  

Transketolase

Research Areas:  

Infection Cancer

Transketolase-IN-4 is a potent inhibitor of transketolase with an IC50 value of 3.9 μM. Transketolase-IN-4 inhibits the proliferation of tumor cells including SW620, LS174T and MIA PaCa-2. Transketolase-IN-4 can be used for tumor research .
loading...
    loading...
Cat. No.: HY-137632
CAS No.: 142754-28-7
Target:  

PKA

Research Areas:  

Cancer

Sp-8-Cl-cAMPS is an analog of cAMP (HY-B1511) and a derivative of Sp-8-Cl-cAMP. Sp-8-Cl-cAMPS inhibits the growth of human leukemia cell HL-60 and colon cancer cell LS-174T, with IC50 of 8-100 μM. Sp-8-Cl-cAMPS activates the protein kinases cAKI and cAKII, with Ka of 0.25 and 3.2 μM .
loading...
    loading...
Cat. No.: HY-P10760
CAS No.: 1616592-31-4
Research Areas:  

Cancer

PhAc-ALGP-Dox, a peptide-drug conjugate, is a novel anticancer prodrug, with IC50 values ranged from 311 nM to 34.25 μM for TNBC (E0771), normal murine epithelium (HC-11), human TNBC (MDA-MB-231 and MDA-MB-468), human CrC (LS 174T), normal human epithelium (HME-1) cells .
loading...
    loading...
Cat. No.: HY-117361
CAS No.: 103828-81-5
Research Areas:  

Cancer

LY207702 is a difluorinated purine nucleoside with antitumor activity and cardiotoxicity. LY207702 is cytotoxic to CEA-positive LS174T cells (IC50=0.302 μg/mL). LY207702 can be used in the study of colon cancer .
loading...
    loading...
Cat. No.: HY-P992339

Research Areas:  

Cancer

cT84.66 is a highly efficient tumor-targeting agent against carcinoembryonic antigen (CEA). cT84.66 engages in bivalent binding with CEA via variable region antigen-binding sites, enabling precise targeting of CEA-producing tumor cells for delivery of therapeutic radiation. cT84.66 exhibits high tumor uptake rate, rapid clearance rate, and excellent tumor-to-blood ratio. With dual functions as an imaging agent and an antibody-directed radiotherapy agent, cT84.66 is widely used in studies of colorectal cancer and metastatic CEA-positive malignancies .
loading...
    loading...